Maria Vincenza Carriero

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Venues

Cells

Scientific reports

International journal of nanomedicine

Istituto Nazionale Tumori IRCCS Fondazione Pascale

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istituto Nazionale Tumori IRCCS Fondazione Pascale May 15 1987

Italy

Chief Tumor Progression Unit :: Experimental Oncology

Publications

Vincenzo Ingangi, Annarosaria De Chiara, Gerardo Ferrara, Michele Gallo, Antonio Catapano, Flavio Fazioli, Gioconda Di Carluccio, Elisa Peranzoni, Ilaria Marigo, Maria Vincenza Carriero, Michele Minopoli
Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma. Cells 13 (11) (2024)
Vincenzo Ingangi, Annarosaria De Chiara, Gerardo Ferrara, Michele Gallo, Antonio Catapano, Flavio Fazioli, Gioconda Di Carluccio, Elisa Peranzoni, Ilaria Marigo, Maria Vincenza Carriero, Michele Minopoli
Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma. Cells 13 (11) (2024)
Vincenzo Ingangi, Annarosaria De Chiara, Gerardo Ferrara, Michele Gallo, Antonio Catapano, Flavio Fazioli, Gioconda Di Carluccio, Elisa Peranzoni, Ilaria Marigo, Maria Vincenza Carriero, Michele Minopoli
Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma. Cells 13 (11) (2024)
Tania Mariastella Caputo, Angela Maria Cusano, Sofia Principe, Paola Cicatiello, Giorgia Celetti, Anna Aliberti, Alberto Micco, Menotti Ruvo, Maria Tagliamonte, Concetta Ragone, Michele Minopoli, Maria Vincenza Carriero, Luigi Buonaguro, Andrea Cusano
Sorafenib-Loaded PLGA Carriers for Enhanced Drug Delivery and Cellular Uptake in Liver Cancer Cells. International journal of nanomedicine 18 (2023)
Michele Minopoli, Andrea Polo, Concetta Ragone, Vincenzo Ingangi, Gennaro Ciliberto, Antonello Pessi, Sabrina Sarno, Alfredo Budillon, Susan Costantini, Maria Vincenza Carriero
Structure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity. Scientific reports 9 (1) (2019)

Maria Vincenza Carriero.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Maria Vincenza Carriero